Saturday - October 10, 2026
FDA Recall Notice: Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital Sodium 500 Mg/vial CIV Due to the Presence of Particulate Matter
October 10, 2026
WASHINGTON, Oct. 10 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following recall notice:

* * *

Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital(R) Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter

Summary

Company Announcement Date: October 08, 2026

FDA Publish Date: October 09, 2026

Product Type: . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products